By Xu Aiying and Kim Hayeon
The World Health Organization (WHO) on Feb. 23 named Korea as the site of its Global Biomanufacturing
Workforce Training Hub.
WHO Director-General Tedros Adhanom Ghebreyesus told an online event for the facility that he was happy
to announce Korea's designation.
On the reasons for the selection, the global health body cited the manufacturing capacity for vaccines
and bioproducts by Korean corporations, training facility infrastructure and the government's active
willingness.
President Moon Jae-in on Feb. 24 welcomed the decision, saying on social media, "This is the result of
Korea's internationally recognized excellence for its biopharmaceutical production capacity and training
infrastructure."
"This is the international community's assessment of the government's leading contributions to
overcoming the global health crisis by strengthening vaccine cooperation with various countries and
organizations, like the Korea-U.S. global vaccine partnership."
"We will actively share our experience and know-how with the international community and contribute to
vaccine self-sufficiency and resolution of vaccine inequality," he added. "The government's goal of
becoming a top-five world vaccine power and a leading country in the bio sector is approaching
reality."
Source : korea.net